About
Monoclonal Antibody, Small Molecule
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyBiotech
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
322
By Phase
PHASE3: 1PHASE2/PHASE3: 1
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07200908Lead Sponsor
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
PHASE3Recruiting
172 participants
Started: Aug 27, 2025 · Completed: Sep 30, 2029
NCT06907290Lead Sponsor
A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection
PHASE2/PHASE3Recruiting
150 participants
Started: Mar 25, 2025 · Completed: Jun 30, 2028
Locations (1)
Headquarters
Redwood City, CA, United States
Map
Loading map...